The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $393.41M |
| Net Income (Most Recent Fiscal Year) | $-64.66M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.71 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -14.40% |
| Net Margin (Trailing 12 Months) | -13.21% |
| Return on Equity (Trailing 12 Months) | -1527.21% |
| Return on Assets (Trailing 12 Months) | -35.30% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.68 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.39 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 27.55 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.05 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.14 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.71 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.64 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Common Shares Outstanding | 98.38M |
| Free Float | 90.02M |
| Market Capitalization | $329.58M |
| Average Volume (Last 20 Days) | 1.72M |
| Beta (Past 60 Months) | 0.15 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 8.50% |
| Percentage Held By Institutions (Latest 13F Reports) | 36.86% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |